Seeking Alpha

Oncolytics Biotech (ONCY -1.5%) dips after closing out its previously announced underwritten...

Oncolytics Biotech (ONCY -1.5%) dips after closing out its previously announced underwritten public offering of 8M shares at $4.  The company intends to use the net proceeds from the offering to fund its clinical trial and manufacturing program.
Comments (1)
  • TruffelPig
    , contributor
    Comments (4091) | Send Message
     
    Many biotech companies dipped today - I do not see any relationship between the two events.
    25 Feb 2013, 12:42 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector